Concepedia

Stuart Kupfer

SK

61

Publications

8.5K

Citations

34

H-Index

1996

Active since

Affiliations

Takeda (United States)(Current)

Brigham and Women's Hospital

Cytokinetics (United States)

Harvard University

University of Glasgow

Stuart Kupfer is an author at Takeda (United States) specializing in medicine, cardiovascular disease, and diabetes.

ORCID

Top concepts

Publications per year

1996–2025

61

Publications

61

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

William B. White, Christopher P. Cannon, Simon Heller et al. · New England Journal of Medicine · 2013 · 2.5K citations · Full text

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

Steven E. Nissen, Stephen J. Nicholls, Kathy Wolski et al. · JAMA · 2008 · 846 citations

Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

Franz H. Messerli, Giuseppe Mancia, C Conti et al. · Annals of Internal Medicine · 2006 · 773 citations

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

Faı̈ez Zannad, Christopher P. Cannon, William C. Cushman et al. · The Lancet · 2015 · 748 citations

, , +11

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke

Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke · 2007 · 473 citations

Rows per page

1–5 of 61